hydron;2,2,3-trimethylpentan-3-amine;chloride

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: hydron;2,2,3-trimethylpentan-3-amine;chloride
• 化学式: C8H20ClN
• 分子量: 165.7
• InChiKey: QBHGSHIHGCUFKE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.58
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  26
• 氢给体数：
  2
• 氢受体数：
  1

文献信息

• [EN] AN IMPROVED PROCESS FOR THE PREPARATION OF LURASIDONE HYDROCHLORIDE<br/>[FR] PROCÉDÉ AMÉLIORÉ DE PRÉPARATION DE CHLORHYDRATE DE LURASIDONE
  申请人：JUBILANT GENERICS LTD FORMERLY JUBILANT LIFE SCIENCES DIVISION

  公开号：WO2016059649A1

  公开（公告）日：2016-04-21

  Disclosed herein is an improved process for the preparation of Lurasidone and its pharmaceutically acceptable salts via novel intermediate and use thereof for the preparation of an antipsychotic agent useful for the treatment of schizophrenia and bipolar disorder. Further, present invention provides a cost effective and eco-friendly process for producing Lurasidone hydrochloride of formula (I) substantially free of residual solvent(s) at industrial scale.

  本文披露了一种改进的工艺，通过新颖的中间体及其用途，用于制备Lurasidone及其药用可接受盐，用于制备一种抗精神分裂症和双相情感障碍治疗有用的抗精神病药物。此外，本发明提供了一种成本效益和环保的工艺，用于在工业规模上生产几乎不含残留溶剂的盐酸Lurasidone（化学式（I））。
• [EN] PROCESS FOR THE PREPARATION OF ROFLUMILAST<br/>[FR] PROCEDE DE PREPARATION DE ROFLUMILAST
  申请人：RANBAXY LAB LTD

  公开号：WO2005026095A1

  公开（公告）日：2005-03-24

  The present invention relates to a process for the preparation of 3-cyclopropylmethoxy-4-difluromethoxy benzoic acid of structural Formula I, and to the use of this compound as an intermediate for the preparation of roflumilast.

  本发明涉及一种制备结构式I中的3-环丙基甲氧基-4-二氟甲氧基苯甲酸的方法，以及将该化合物用作制备洛氟米拉斯特的中间体的用途。
• Process for preparation of allyl sulfone derivatives and intermediates for the preparation
  申请人：——

  公开号：US20040054233A1

  公开（公告）日：2004-03-18

  The present invention relates to a process for producing an allyl sulfone derivative represented by the formula (3): 1 wherein Ar is an optionally substituted aryl group, and the corrugated line means either one of E/Z geometrical isomers, or a mixture thereof, which is an intermediate for producing vitamin A, which process is characterized by reacting an aryl sulfinic acid or a salt thereof represented by the formula (2): ArSO 2 M (2) wherein Ar is as defined above, and M is hydrogen atom, sodium atom or potassium atom, with an allyl halide derivative represented by the formula (1): 2 wherein X is a halogen atom, and Ar and the corrugated line are as defined above.

  本发明涉及一种制备烯丙基磺酰衍生物的方法，该衍生物由公式（3）表示：其中Ar是一种可选取的取代芳基，而波浪线表示E/Z几何异构体之一或其混合物，是生产维生素A的中间体。该方法的特点在于，将由公式（2）表示的芳基亚磺酸或其盐（其中Ar如上定义，M为氢原子、钠原子或钾原子）与由公式（1）表示的烯丙基卤化衍生物反应（其中X为卤素原子，Ar和波浪线如上定义）。
• [EN] PROCESS FOR THE PREPARATION OF DONEPEZIL AND DERIVATIVES THEREOF<br/>[FR] PROCEDE DE PREPARATION DE DONEPEZIL ET DE SES DERIVES
  申请人：RANBAXY LAB LTD

  公开号：WO2004082685A1

  公开（公告）日：2004-09-30

  The invention relates to processes for the preparation of piperidylmethyl-indanones, and to the use of these compounds as intermediates for the preparation of benzyl-piperidylmethyl-indanones which are active compounds for the treatment of CNS disorders. The invention also relates to a process for the preparation of donepezil or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions that include the donepezil or a pharmaceutically acceptable salt thereof.

  本发明涉及制备哌啶甲基-茚烷酮的方法，以及使用这些化合物作为中间体制备苯甲基-哌啶甲基-茚烷酮，后者是治疗中枢神经系统疾病的活性化合物。本发明还涉及制备多奈哌齐或其药学上可接受的盐的方法，以及包括多奈哌齐或其药学上可接受的盐的制药组合物。
• Dihalo-compound and process for producing vitamin A derivative
  申请人：——

  公开号：US20010025127A1

  公开（公告）日：2001-09-27

  There is disclosed a dihalo-compound of formula (1): 1 wherein X 1 and X 2 represent different halogen atoms, R represents a hydrogen atom or a protective group for a hydroxyl group, and a process for producing vitamin A derivative via a sulfone derivative of formula (5): 2 wherein Ar represents an optionally substituted aryl group, and R represents the same as defined above.

  公开了一种式子为（1）的二卤代化合物：1其中X1和X2代表不同的卤素原子，R代表氢原子或羟基的保护基团，并且通过式子为（5）的磺酰衍生物制备维生素A衍生物的方法：2其中Ar代表可选取代的芳基团，R与上述定义相同。